title: Azithromycin in acute bacterial upper respiratory tract infections: an Indian non-interventional study.
abstract: To assess the effectiveness, safety and tolerability of azithromycin in acute bacterial upper respiratory tract infections (URTIs). In this open-label, prospective, multi-center, non-interventional study in bacterial URTI, the decision to prescribe azithromycin was independent of enrolment. Follow up was 1 week after treatment and if possible, at Week 2. Investigators' assessment of clinical outcome (Success/Failure) at the end of study was the primary endpoint for efficacy analysis. Clinical outcome of 'Success' was defined as the global response of Cure or Improvement. A pharmacoeconomic analysis of management of URTIs was also attempted. Of the 410 patients recruited, all were evaluated for safety and 278 for efficacy. The median treatment duration was 3 days. Following treatment with azithromycin, overall success rate was 98.92% (95% CI 96.88-99.78%; Clopper-Pearson method). The success rate was similar across the sub-groups of acute otitis media-100%, bacterial sinusitis-95.83%, and pharyngotonsillitis-99.38%. The success rate was 100% among children and adolescents (age ≤18 years) and 98.6% among adults (age >18 years). Most of the common signs and symptoms of URTI reported during baseline, significantly improved at the end of the study. Sixteen (3.90%) patients reported treatment emergent adverse events, the most common being diarrhea-5 (1.2%) and flatulence-2 (0.5%). The average cost of treating bacterial URTI was INR 716 per patient. Azithromycin is effective and well tolerated in Indian patients with bacterial URTIs.
authors.affiliation: Pfizer Limited, Pfizer Centre, Patel Estate, S.V.Road, Jogeshwari (W), Mumbai, 400 102 India.
authors.forename: Shaantanu
authors.initials: S
authors.lastname: Donde
authors.affiliation: Pfizer Limited, Pfizer Centre, Patel Estate, S.V.Road, Jogeshwari (W), Mumbai, 400 102 India.
authors.forename: Anupam
authors.initials: A
authors.lastname: Mishra
authors.affiliation: Pfizer Limited, Pfizer Centre, Patel Estate, S.V.Road, Jogeshwari (W), Mumbai, 400 102 India.
authors.forename: Puja
authors.initials: P
authors.lastname: Kochhar
keywords: Antibiotics; Azithromycin; Macrolides; Non-interventional study; Upper respiratory tract infections (URTI)